Conservation and variability of West Nile virus proteins

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Koo, Qi Ying ^a   Khan, Asif M ^a   Jung, Keun Ok ^b   Ramdas, Shweta ^a   Miotto, Olivo ^a,c,d   Tan, Tin Wee ^a   Brusic, Vladimir ^e   Salmon, Jerome ^b   August, J Thomas ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MAHIDOL UNIVERSITY   (Thailand)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROORGANISM PROTEIN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 2A; NONSTRUCTURAL PROTEIN 2B; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5; PROTEIN C; PROTEIN E; PROTEIN PRM; UNCLASSIFIED DRUG; VIRUS PROTEIN; EPITOPE; HLA ANTIGEN; PROTEOME; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; ENTROPY; FLAVIVIRUS; GENETIC CONSERVATION; GENETIC VARIABILITY; IMMUNOGENICITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; T LYMPHOCYTE; WEST NILE FLAVIVIRUS; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PROTEIN DATABASE;

ANIMALIA; WEST NILE VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CONSERVED SEQUENCE; DATABASES, PROTEIN; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; GENETIC VARIATION; HLA ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEOME; VIRAL PROTEINS; WEST NILE VIRUS;

EID: 65549120233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005352     Document Type: Article

References (51)

1. Horga MA, Fine A (2001) West Nile virus. Pediatr Infect Dis J 20: 801-802.
2. Petersen LR, Roehrig JT (2001) West Nile virus: a reemerging global pathogen. Emerg Infect Dis 7: 611-614.
3. Marfin AA, Petersen LR, Eidson M, Miller J, Hadler J, et al. (2001) Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis 7: 730-735.
4. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, et al. (1999) Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333-2337.
5. Petersen LR, Marfin AA, Gubler DJ (2003) West Nile virus. JAMA 290: 524-528.
6. Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, et al. (2005) Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 11: 1174-1179.
7. Domingo E (1997) RNA virus evolution, population dynamics, and nutritional status. Biol Trace Elem Res 56: 23-30.
8. Elena SF, Carrasco P, Daros JA, Sanjuan R (2006) Mechanisms of genetic robustness in RNA viruses. EMBO Rep 7: 168-173.
9. Bondre VP, Jadi RS, Mishra AC, Yergolkar PN, Arankalle VA (2007) West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol 88: 875-884.
10. Lanteri MC, Heitman JW, Owen RE, Busch T, Gefter N, et al. (2008) Comprehensive analysis of west nile virus-specific T cell responses in humans. J Infect Dis 197: 1296-1306.
11. Wang Y, Lobigs M, Lee E, Mullbacher A (2003) CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77: 13323-13334.
12. Cheng Y, King NJ, Kesson AM (2004) Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. J Infect Dis 189: 658-668.
13. Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, et al. (2006) Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 80: 5338-5348.
14. Brien JD, Uhrlaub JL, Nikolich-Zugich J (2007) Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur J Immunol 37: 1855-1863.
15. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, et al. (2007) Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37: 1845-1854.
16. Khan AM, Miotto O, Heiny AT, Salmon J, Srinivasan KN, et al. (2006) A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell Immunol 244: 141-147.
17. Khan AM, Miotto O, Nascimento EJ, Srinivasan KN, Heiny AT, et al. (2008) Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis 2: e272.
18. Heiny AT, Miotto O, Srinivasan KN, Khan AM, Zhang GL, et al. (2007) Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS ONE 2: e1190.
19. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2005) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 33: D39-45.
20. McGinnis S, Madden TL (2004) BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res 32: W20-25.
21. O'Donovan C, Martin MJ, Gattiker A, Gasteiger E, Bairoch A, et al. (2002) High-quality protein knowledge resource: SWISS-PROT and TrEMBL. Brief Bioinform 3: 275-284.
22. Edgar RC (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32: 1792-1797.
23. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
24. Shannon CE (1948) A mathematical theory of communication. Bell System Technical Journal 27: 379-423 and 623-656.
25. Miotto O, Heiny A, Tan TW, August JT, Brusic V (2008) Identification of human-to-human transmissibility factors in PB2 proteins of influenza A by large-scale mutual information analysis. BMC Bioinformatics 9 Suppl 1: S18.
26. Rammensee HG (1995) Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 7: 85-96.
27. Hulo N, Bairoch A, Bulliard V, Cerutti L, De Castro E, et al. (2006) The PROSITE database. Nucleic Acids Res 34: D227-230.
28. de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, et al. (2006) ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res 34: W362-365.
29. Bateman A, Coin L, Durbin R, Finn RD, Hollich V, et al. (2004) The Pfam protein families database. Nucleic Acids Res 32: D138-141.
30. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242.
31. Peters B, Sidney J, Bourne P, Bui HH, Buus S, et al. (2005) The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 3: e91.
32. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, et al. (2005) An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 35: 2295-2303.
33. Zhang GL, Khan AM, Srinivasan KN, August JT, Brusic V (2005) MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res 33: W172-179.
34. Bui HH, Sidney J, Peters B, Sathiamurthy M, Sinichi A, et al. (2005) Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57: 304-314.
35. Bian H, Hammer J (2004) Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods 34: 468-475.
36. Valdar WS (2002) Scoring residue conservation. Proteins 48: 227-241.
37. Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, et al. (2006) Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80: 11000-11008.
38. Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ (2003) Structure of West Nile virus. Science 302: 248.
39. Li H, Clum S, You S, Ebner KE, Padmanabhan R (1999) The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol 73: 3108-3116.
40. Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, et al. (2006) Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 13: 372-373.
41. Feito MJ, Gomez-Gutierrez J, Ayora S, Alonso JC, Peterson D, et al. (2008) Insights into the oligomerization state-helicase activity relationship of West Nile virus NS3 NTPase/helicase. Virus Res 135: 166-174.
42. Mackenzie JM, Kenney MT, Westaway EG (2007) West Nile virus strain Kunjin NS5 polymerase is a phosphoprotein localized at the cytoplasmic site of viral RNA synthesis. J Gen Virol 88: 1163-1168.
43. Malet H, Egloff MP, Selisko B, Butcher RE, Wright PJ, et al. (2007) Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5. J Biol Chem 282: 10678-10689.
44. Zhang GL, Khan AM, Srinivasan KN, Heiny A, Lee K, et al. (2008) Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes. BMC Bioinformatics 9 Suppl 1: S19.
45. Smithburn KC, Hughes TP, Burke AW, Paul JH (1940) A neurotropic virus isolated from the blood of a native of Uganda. American Journal of Tropical Medicine 20: 471-492.
46. Biswas T, Aihara H, Radman-Livaja M, Filman D, Landy A, et al. (2005) A structural basis for allosteric control of DNA recombination by lambda integrase. Nature 435: 1059-1066.
47. Gottesman ME, Weisberg RA (2004) Little lambda, who made thee? Microbiol Mol Biol Rev 68: 796-813.
48. Crochu S, Cook S, Attoui H, Charrel RN, De Chesse R, et al. (2004) Sequences of flavivirus-related RNA viruses persist in DNA form integrated in the genome of Aedes spp. mosquitoes. J Gen Virol 85: 1971-1980.
49. Freeman S (2003) Biological Science. NJ, USA: Prentice Hall.
50. Kurane I, Okamoto Y, Dai LC, Zeng LL, Brinton MA, et al. (1995) Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones. J Gen Virol 76(Pt 9): 2243-2249.
51. De Groot AS, Saint-Aubin C, Bosma A, Sbai H, Rayner J, et al. (2001) Rapid determination of HLA B*07 ligands from the West Nile virus NY99 genome. Emerg Infect Dis 7: 706-713.